Product Information
CEFDINIR 250 MG/5 ML SUSP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1210 per ML under NDC 67877054888. Its NADAC has been published 261 times since Jun 30, 2021.
Strength
250 mg/5mL
Manufacturer
Ascend Laboratories, LLCNDC
67877054888
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFDINIRApproval Type
Generic (ANDA)
FDA Application
ANDA210534On Market Since
2/20/2021
Pharmacological Classes
Price Statistics
The NADAC for CEFDINIR 250 MG/5 ML SUSP has been published 261 times since Jun 30, 2021, and over the history we have for it it has declined 30.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1210 per ML |
|---|---|
| All-time high | $0.2195 (Apr 12, 2023) |
| All-time low | $0.1127 (Nov 20, 2024) |
| 52-week high | $0.1403 |
| 52-week low | $0.1159 |
| Median price | $0.1506 |
| Average price | $0.1535 |
| Largest weekly change | +47.5% (Mar 22, 2023) |
| Weeks tracked | 261 |
| Tracking since | Jun 30, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFDINIR 250 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFDINIR 250 MG/5 ML SUSP, manufactured by Ascend Laboratories, LLC, is $0.1210 per ML (NDC 67877054888), effective Jun 24, 2026.
How has the price of CEFDINIR 250 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFDINIR 250 MG/5 ML SUSP has declined 30.3%. It has been tracked across 261 weekly CMS publications since Jun 30, 2021.
What are the highest and lowest recorded NADAC prices for CEFDINIR 250 MG/5 ML SUSP?
Since Jun 30, 2021, the NADAC for CEFDINIR 250 MG/5 ML SUSP has ranged from a low of $0.1127 (Nov 20, 2024) to a high of $0.2195 (Apr 12, 2023), with a median of $0.1506 per ML.
Are there cheaper alternatives to CEFDINIR 250 MG/5 ML SUSP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CEFDINIR 250 MG/5 ML SUSP, but none are currently priced below it.
Who manufactures CEFDINIR 250 MG/5 ML SUSP?
CEFDINIR 250 MG/5 ML SUSP (NDC 67877054888) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification